MedAI Verdict
All comparisons

DeepHealth vs TeraRecon

A hospital radiology department can set these two against each other as a cleared mammography detector and a platform that hosts third-party algorithms. DeepHealth's Saige-Dx has openFDA clearances from May 2022 through K253825 in June 2026. A vendor-affiliated reader study in Radiology: AI (18 readers, 240 cases, retrospective, enriched set, authors employed by DeepHealth) reported AUC 0.93 against 0.87, with gains of 0.08 for general radiologists and 0.05 for specialists.

TeraRecon's algorithm clearances cover MR mapping, CT and MR perfusion, cardiac chambers on MR (K241312), the aorta on CT (K243158) and coronary calcium on CT (K250288, decided October 23, 2025). Its AI Framework hosts third-party algorithms, shows Gleamer and Infervision among its partner logos, and returns results over DICOM and HL7. Its newsroom lists a February 25, 2025 partnership with RadNet's DeepHealth. Cardiac CT, structural heart planning and neuro perfusion point to TeraRecon.

For the screening mammography detector itself, TeraRecon loses, since none of its openFDA algorithm records is a mammography detection tool.

Radiology · Reviewed November 2, 2026

DeepHealth logo

DeepHealth

by RadNet / DeepHealth, Inc.

Imaging AI from RadNet's DeepHealth: mammography (Saige-Dx, Saige-Density), breast arterial calcification, prostate, lung, bone and chest X-ray.

TeraRecon logo

TeraRecon

by ConcertAI · founded 1997

Advanced CT and MR visualization with cardiac, aorta and neuro AI, plus a vendor-agnostic platform to run third-party AI.

When to pick each one

DeepHealth

  • Saige-Dx mammography detection with a reader study
  • Enterprise imaging suites for radiology departments
Read the full DeepHealth review

TeraRecon

  • Aorta, cardiac MR and coronary calcium algorithms
  • AI Framework hosts third-party algorithms via DICOM and HL7
Read the full TeraRecon review

Score

Each row shows points earned of points available under the published rubric.

DeepHealth

48of 100

Solid choice

TeraRecon

42of 100

Competitive
Score by dimension for DeepHealth and TeraRecon
DimensionDeepHealthTeraReconDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers7.3 / 18.20 / 18.2+7.3
RCT / meta-analysis / systematic review0 / 7.80 / 7.80
Funding & adoption signal12 / 128.4 / 12+3.6
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 66 / 6-6

Scroll horizontally to see every column.

How scores are computed

Pricing

DeepHealth

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. The homepage shows none.

TeraRecon

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

DeepHealth

FDA decisions

Show 13 more

Peer-reviewed

1 PubMed record names DeepHealth.

TeraRecon

FDA decisions

Show 2 more

Compliance and integrations

Documented from each vendor’s own pages.

SpecDeepHealthTeraRecon
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/a1997
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.